Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders

 April 10, 2026

BioPharma Dive

The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety.

Policy / PricingRead full story

Post navigation

With oral obesity race underway, all eyes are on Lilly’s Foundayo launch →
← Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com